What is the recommended dose of Allegra (fexofenadine) for itching in the lower limbs?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Dose of Allegra (Fexofenadine) for Itching in Lower Limbs

For itching in the lower limbs, the recommended dose of fexofenadine is 60 mg twice daily or 180 mg once daily for adults and children 12 years and older. 1

Standard Dosing Based on FDA Labeling

  • Adults and children ≥12 years: 60 mg twice daily OR 180 mg once daily with water 1
  • Children 6-11 years: 30 mg twice daily with water 1
  • The 180 mg once-daily dosing provides equivalent efficacy to 60 mg twice daily with the convenience of single daily administration 2, 1

Clinical Evidence Supporting This Dose

  • Multiple controlled trials demonstrate that fexofenadine 60 mg twice daily or 180 mg once daily provides statistically superior relief of pruritus compared to placebo 3, 4
  • The 60 mg twice-daily dose showed 95% improvement rates in patients with chronic pruritic conditions, with 91% reporting very favorable responses (excellent to good) 5
  • In a large prospective study of 512 patients with chronic pruritus, 180 mg daily reduced mean total symptom scores to zero by 4 weeks in most patients 6

Why Fexofenadine is Preferred for Pruritus

  • Non-sedating profile: Fexofenadine maintains non-sedating properties even at doses up to 240 mg daily, unlike first-generation antihistamines 7, 4
  • Safety margin: Well-tolerated at doses up to 11 times the recommended therapeutic dose with no dose-related adverse effects 8
  • Rapid onset: Reaches peak concentrations in 0.83-1.33 hours with significant antihistaminic activity 8
  • Quality of life: Does not impair psychomotor performance or driving ability, making it suitable for daytime use 4

Special Populations and Dose Adjustments

  • Renal impairment: Start with 60 mg once daily (instead of twice daily or 180 mg) in patients with decreased renal function 1
  • Elderly patients: No dose adjustment required based on age alone 2
  • Hepatic impairment: Well-tolerated without specific dose reduction needed 4

Important Clinical Considerations

  • Timing: Take with water; avoid fruit juices (especially grapefruit, orange, or apple juice) as they may reduce absorption 1
  • Duration: Most patients show significant improvement within 1-4 weeks 6
  • Safety profile: Adverse events are mild and similar to placebo, with headache (9%) being most common; no reports of drowsiness or cardiac arrhythmias 6

When to Consider Alternative or Additional Therapy

  • If symptoms persist after 2 weeks at standard dosing, consider adding an H2 antihistamine (famotidine or cimetidine) rather than increasing fexofenadine dose 9
  • For localized lower limb itching, combine with high-lipid content emollients and moderate-potency topical corticosteroids 10, 9
  • Avoid first-generation antihistamines (diphenhydramine, hydroxyzine) due to sedation and cognitive impairment, especially in elderly patients 9

Common Pitfalls to Avoid

  • Do not exceed 180 mg once daily as the standard therapeutic dose; higher doses (up to 240 mg daily) show similar efficacy without additional benefit 3, 4
  • Do not use sedating antihistamines as alternatives, particularly in patients who need to maintain alertness for work or driving 7
  • Do not assume all pruritus is histamine-mediated: If no improvement after 2-4 weeks, investigate for underlying systemic causes (renal, hepatic, hematologic disorders) 9

References

Guideline

Fexofenadine Dosage and Safety

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

The systemic safety of fexofenadine HCl.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 1999

Guideline

Fexofenadine for Itching in Allergic Reactions

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Evaluation and Management of Generalized Itching and Welts

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.